09:45 AM EST - Miraculins Inc. : announced that previously unpublished data from a major study of more than 9,000 North American life insurance applicants, could open the door for skin cholesterol testing to be utilized as a new risk assessment tool in U.S. life insurance underwriting. The new findings, resulting from supplemental data analysis of the study, showed that smokers with elevated skin cholesterol were at significantly increased probability of having multiple cardiovascular disease risk factors, as compared to smokers with lower skin cholesterol levels. Miraculins Inc.
shares V.MOM are trading unchanged at $0.06.
